Background-Immune responses participate in several phases of atherosclerosis; there is, in fact, increasing evidence that both adaptive immunity and innate immunity tightly regulate atherogenesis. Pentraxins are a superfamily of acute-phase proteins that includes short pentraxins such as C-reactive protein or long pentraxins such as PTX3, a molecule acting as the humoral arm of innate immunity. To address the potential role of PTX3 in atherogenesis, we first investigated the expression of PTX3 during atherogenesis, generated double-knockout mice lacking PTX3 and apolipoprotein E, and then studied the effect of murine PTX3 deficiency on plasma lipids, atherosclerosis development, and gene expression pattern in the vascular wall. Methods and Results-PTX3 expression increases in the vascular wall of apolipoprotein E-knockout mice from 3 up to 18 months of age. Double-knockout mice lacking PTX3 and apolipoprotein E were fed an atherogenic diet for 16 weeks. Aortic lesions were significantly increased in double-knockout mice and mice heterozygous for PTX3 compared with apolipoprotein E-knockout mice. Mice lacking PTX3 showed a more pronounced inflammatory profile in the vascular wall as detected by cDNA microarray and quantitative polymerase chain reaction analysis and an increased macrophage accumulation within the plaque. Finally, lesion size correlated with the number of bone marrow monocytes. Conclusion-PTX3 has atheroprotective effects in mice, which, in light of the cardioprotective effects recently reported, suggests a cardiovascular protective function of the long pentraxin 3 through the modulation of the immunoinflammatory balance in the cardiovascular system. (Circulation. 2009;120:699-708.)
I mmune responses participate in several phases of atherosclerosis; and both adaptive immunity and innate immunity are believed to tightly regulate atherogenesis. 1 Pentraxins, an essential component of the humoral arm of innate immunity, are a superfamily of acute-phase proteins highly conserved during evolution and characterized by a multimeric, usually pentameric, structure. 2 The pentraxin family is composed of the short pentraxins such as C-reactive protein (CRP) and serum amyloid P component (SAP) and by long pentraxins such as PTX3, which shows similarities to CRP and SAP but has an unrelated, long N-terminal domain coupled to the C-terminal pentraxin domain and differs in gene organization, cellular source, and ligands recognized. 3 
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Experimental evidence on the role of CRP in atherogenesis and vascular disease is mixed. 4, 5 A proatherogenic role for CRP in vivo when overexpressed in apolipoprotein E-knock-out (ApoE Ϫ/Ϫ ) mice has been shown 6 ; however, subsequent work failed to confirm this observation in either human CRP 7 or rabbit CRP transgenic mice 8 on ApoE Ϫ/Ϫ or ApoE*3-Leiden background. 9 The possibility that pentameric versus monomeric CRP affects atherogenesis development differently may explain these discrepancies. 10 In addition, the evidence for a role of CRP in other vascular phenotypes is mixed; although Danenberg et al 11 observed a prothrombotic effect of CRP in mice, Tennent et al 12 failed to confirm these findings. Furthermore, CRP has been shown to adversely affect vascular remodeling and blood pressure. 13, 14 CRP sequence and regulation have not been conserved in evolution from mouse to human. Indeed, mouse CRP does not behave as an acute-phase protein, and human CRP does not bind mouse C1q, 15 thus hampering assessment of its in vivo function through genetic and pharmacological approaches to determine its role in human pathology. On the contrary, the conservation of sequence, gene organization, and regulation of PTX3 in evolution allows us to address questions about the pathophysiological roles of PTX3 using gene-modified mice. 16 PTX3 is rapidly produced and released by several cell types, particularly mononuclear phagocytes, dendritic cells, fibroblasts, and endothelial cells in response to either inflammatory or atheroprotective signals. 3, [17] [18] [19] [20] Recent studies in gene-modified mice showed that PTX3 has complex, nonredundant functions in vivo, ranging from the assembly of a hyaluronic acid-rich extracellular matrix and female fertility to innate immunity against diverse microorganisms. 3,21-23 PTX3 was initially described as an early marker for primary local activation of innate immunity and inflammatory responses 24, 25 ; is highly expressed in the heart during inflammatory reactions, in atherosclerotic lesions, and in vascular cells in response to inflammatory stimuli; and is increased in plasma in patients with arterial inflammation, particularly unstable angina pectoris. 26 -29 Whether PTX3 plays a role in the pathogenesis of vascular diseases, however, is unclear. PTX3 is a potent inhibitor of the autocrine and paracrine stimulation exerted by fibroblast growth factor-2. 30 In a model of lipopolysaccharide toxicity and in cecal ligation and puncture, PTX3 overexpression resulted in increased resistance. 24 Furthermore, in a model of acute myocardial infarction caused by coronary artery ligation, PTX3-deficient mice showed increased heart damage associated with a greater no-reflow area and increased inflammatory response, a phenotype reversed by exogenous PTX3. 16 Together, these data support a cardioprotective function of PTX3.
To address the potential role of PTX3 in atherogenesis, we generated double-knockout mice lacking PTX3 and ApoE and studied the effect of murine PTX3 deficiency on lipid metabolism, atherosclerosis development, and gene expression patterns in the vascular wall.
Methods
Detailed descriptions of the generation of double-transgenic animals and treatment, plasma lipid analysis and atherosclerosis quantification, cDNA microarray and quantitative polymerase chain reaction analyses, immunohistochemistry, and statistics are presented in the online-only Data Supplement. All experimental procedures were in accordance with the institutional guidelines for animal research. The cDNA microarray experiments were performed according to the Minimum Information About a Microarray Experiment guidelines. The raw data for each hybridization and the final processed files are accessible at the following address: http://www.sisalombardia.it/dati3/dati3.htm.
Results

PTX3 Expression in ApoE ؊/؊ Mouse Aorta
To evaluate the expression of PTX3 during atherogenesis, we performed a time-course experiment in ApoE Ϫ/Ϫ mice fed a chow diet and investigated PTX3 mRNA and protein expression in the aortas. Compared with 3 months of age, PTX3 mRNA expression at 12 and 18 months of age was significantly increased (3.11Ϯ0.24-and 2.55Ϯ0.32-fold versus 3-month-old mice, respectively; PϽ0.01; Figure 1A ). This effect was specific for PTX3 because neither the CRP nor SAP mRNA level was changed throughout the experiment ( Figure 1A ). In agreement, PTX3 protein expression increased in the atherosclerotic plaque ( Figure I 
Quantitative Morphometry of Atherosclerosis in Double-Knockout Mice
After 16 weeks on a Western-type diet, the double-knockout mice showed no significant differences in body weight or plasma lipids (the Table) . Mice lacking PTX3 had an increased atherosclerotic lesion area in the aortic sinus and ascendant aorta (the Table, increase in atherosclerotic lesion area in the aortic sinus (PϽ0.05 for all) compared with PTX3 ϩ/ϩ /ApoE Ϫ/Ϫ mice. Similar results were reported when the ascendant aorta tract was investigated (the Table, Figure 3 , and Figure IIB of the online-only Data Supplement). Overall, female mice developed larger atherosclerotic lesions compared with male mice. This is probably due to the lack of ApoE, which has been reported to affect atherosclerotic lesion formation differently in female and male mice. 31 Indeed, no difference in the vessel was observed in female compared with male PTX3 Ϫ/Ϫ mice (data not shown).
The presence of atherosclerosis in the aorta was then investigated at the thoracic and abdominal levels. Except for 1 double-knockout female, no lesions were observed at the thoracic level ( Figure Similarly, no atherosclerotic lesions were detectable in the thoracic and abdominal aortas from males (data not shown). Next, we investigated the effect of PTX3 deficiency in ApoE Ϫ/Ϫ mice on a chow diet. The extent of atherosclerotic lesions was less compared with mice fed a Western-type diet; indeed, only in 18-month-old female mice, which have a degree of atherosclerosis similar to that reported in mice fed a Western-type diet for 16 weeks, was PTX3 deficiency associated with significantly larger atherosclerotic lesions compared with PTX3 ϩ/ϩ /ApoE Ϫ/Ϫ mice ( Figure IV of the online-only Data Supplement). Of note, PTX3 mRNA expression was increased in C57BL/6J mice fed a Westerntype diet for 4 months (5.6Ϯ0.6-fold in the aortic arch compared with mice fed with the chow diet); however, under these conditions, C57BL/6J mice did not develop detectable atherosclerotic lesions even in the absence of PTX3 ( Figure V of the online-only Data Supplement). We therefore focused the next analysis on only mice on an ApoE Ϫ/Ϫ background.
Gene Expression Analysis in Aorta Atherosclerotic Lesion
Next, we investigated the gene expression patterns in the aorta focusing on the tract between the aortic sinus and the ascending aorta in mice fed a Western-type diet for 16 weeks. A mouse inflammation-focused cDNA microarray was used; the data are reported for each group of animals and according to gender (Figure 4 ). Several genes were modulated in both male and female mice and some were selectively modulated in only 1 gender. Of note, a cluster of proinflammatory molecules such as chemokines (Ccl2, Ccl3, Ccl5, Ccl7, and Ccl8), cytokines (interleukin [IL]-4, IL-6, tumor necrosis factor-␣), and TRAF3 was upregulated in both PTX3 ϩ/Ϫ /ApoE Ϫ/Ϫ and PTX3 Ϫ/Ϫ / ApoE Ϫ/Ϫ mice compared with PTX3 ϩ/ϩ /ApoE Ϫ/Ϫ mice. Furthermore, several transcription factors involved in intracellular proinflammatory signaling such as nuclear factor-B and the related protein Irak1, Fos, Jun, GATA3, GATA4, Egr2, and Egr3 were upregulated in both PTX3 ϩ/Ϫ /ApoE Ϫ/Ϫ or PTX3 Ϫ/Ϫ / ApoE Ϫ/Ϫ mice compared with PTX3 ϩ/ϩ /ApoE Ϫ/Ϫ mice. Finally, key mediators in the inflammatory response as toll-like receptor 2 and 4 or Cox-2 were also upregulated in mice lacking PTX3.
Modulation of the expression of genes involved in inflammatory vascular responses was confirmed by quantitative polymerase chain reaction ( Figure 5 ). The expression of chemokines such as Ccl2, Ccl3, and Ccl5 and receptors as CCR2, CCR5, and CX3CR1 was upregulated in PTX3 ϩ/Ϫ /ApoE Ϫ/Ϫ and PTX3 Ϫ/Ϫ / ApoE Ϫ/Ϫ mice compared with PTX3 ϩ/ϩ /ApoE Ϫ/Ϫ mice, with some minor differences depending on gender ( Figure 5A and 5B). In addition, other key factors such as matrix metalloproteinase-9, IL-6, and insulin-like growth factor were upregulated in mice lacking PTX3. Analysis of the gene expression patterns therefore suggests that the lack of PTX3 in a proatherogenic background may be associated with an increased inflammatory status in the vascular wall, which, in turn, contributes to the atherogenic process observed. To further address this issue, we investigated the mRNA expression of adhesion molecules (key markers of endothelial dysfunction). Increased expression of intracellular adhesion molecule, vascular cell adhesion molecule-1, endothelial leukocyte adhesion molecule-1, and platelet/endothelial cell adhesion molecule mRNA expression was observed in female PTX3 ϩ/Ϫ / ApoE Ϫ/Ϫ and PTX3 Ϫ/Ϫ /ApoE Ϫ/Ϫ mice compared with PTX3 ϩ/ϩ / ApoE Ϫ/Ϫ mice ( Figure 5C , left); except for intracellular adhesion molecule-1, a similar pattern was observed in male mice ( Figure  5C , right). These findings confirm the presence of a vascular dysfunction associated with the lack of functional PTX3. Furthermore, these expression patterns appeared to be specific for the vascular wall; indeed, when investigated in peripheral blood mononuclear cells, no significant differences in the absence of PTX3 were observed ( Figure VI 
Characterization of the Atherosclerotic Lesions
The presence of macrophages ( Figure 6B , 6G, and 6N), smooth muscle cells ( Figure 6D, 6I, and 6P ), and T lymphocytes ( Figure   6E , 6L, and 6Q) also was investigated in the atherosclerotic plaque from PTX3 ϩ/ϩ /ApoE Ϫ/Ϫ mice ( Figure 6A Figure 6P and 6Q) .
Because the atherosclerotic plaque contained several smooth muscle cells ( Figure 6 ), which are known to contribute to plaque stability through the synthesis of collagen, 32 Figure VII and VIII of the online-only Data Supplement) and ascending aorta (data not shown). These observations suggest that PTX3 deficiency is not associated with altered stability of the atherosclerotic plaque.
sinus (
Finally, to investigate possible mechanisms related to the increased presence of macrophages in the plaques, a series of additional experiments were performed. First, peritoneal macrophages isolated from either wild-type mice or mice lacking PTX3 were stimulated with oxidized low-density lipoprotein, but similar proinflammatory gene expression patterns and oxidative stress responses were observed (data not shown). Next, leukocyte subpopulations were investigated in blood and bone marrow in a subgroup of mice. In agreement with recent findings, 33, 34 we observed increased bone marrow and blood monocytosis in ApoE Ϫ/Ϫ mice (data not shown). Furthermore, preliminary findings showed that in ApoE Ϫ/Ϫ female mice, PTX3 deficiency was associated with a more pronounced bone marrow monocytosis that correlated with the extent of atherosclerotic lesions (Figure 7 ), in agreement with Combadiere et al 33 using a different mouse model.
Discussion
Although PTX3 has been described as an early marker for primary local activation of innate immunity and inflammatory response in the vascular wall, 24 there is no genetic evidence in humans of its role in the pathogenesis of vascular disease. In contrast to other pentraxins such as CRP and SAP, the long pentraxin PTX3 is well conserved at the primary sequence, gene organization, and regulation levels from mouse to human. 21 It is thus possible to address the pathophysiological role of PTX3 using gene-modified mice. To this aim, we investigated the role of PTX3 on atherosclerosis in mice lacking PTX3 on an ApoE Ϫ/Ϫ background. PTX3 Ϫ/Ϫ / ApoE Ϫ/Ϫ mice develop larger atherosclerotic lesions, which are associated with an increased proinflammatory gene expression pattern in the vascular wall, increased bone marrow monocytosis, and macrophage accumulation within the plaque. Of note, in ApoE Ϫ/Ϫ mice, increased PTX3 expression was observed in advanced atherosclerotic lesions, confirming previous observations in human atherosclerotic lesions, 27 and was associated with macrophages and polymorphonuclear and endothelial cells. Whether this increase reflects a proatherogenic role of PTX3 or is a marker of a modulation of the immunoinflammatory response in the vascular wall is debated. 35 PTX3 plasma levels predict 3-month mortality in patients with myocardial infarction, even after adjustment for major risk factors and other acute-phase prognostic markers. 25 These results, coupled with those showing the upregulation of endothelial cell tissue factor in response to PTX3, 36 suggested a potential pathogenic role for PTX3 in cardiovascular disease. However, there are at least some exceptions to the modulation of PTX3 expression by inflammatory mediators. The Th1-related and proatherogenic cytokine interferon-␥ seems to be inhibitory, 27 whereas the immunoregulatory and antiatherogenic IL-10 27 stimulates PTX3 expression in dendritic cells and monocytes, 27 thus suggesting a potential antiatherogenic role for PTX3. Furthermore, several studies have clearly shown that efficient apoptotic cell clearance inhibits the inflammatory response and reduces the development of atherosclerosis and the size of the necrotic core. 37, 38 PTX3 binds to apoptotic cells, enhancing C1q binding and complement-mediated clearance of apoptotic cells, 39 and may therefore contribute to limiting the size and complexity of atherosclerotic lesions. In a different setting, however, such as small-vessel vasculitis, PTX3 inhibits phagocytosis of late apoptotic neutrophils, thus promoting their accumulation in the vessel wall. 40 The in vivo role of PTX3 in inflammatory conditions has been investigated through the use of PTX3-overexpressing and -deficient mice. 41 PTX3 inhibits fibroblast growth factor-2-dependent activation of smooth muscle cells in vitro and neointimal formation in vivo. 30 PTX3 overexpression resulted in increased resistance to sepsis in the cecal ligation and puncture model. 24 Furthermore, in a model of acute myocardial infarction caused by coronary artery ligation, PTX3-deficient mice showed exacerbated heart damage with a greater no-reflow area and increased inflammatory response; this phenotype was reversed by exogenous PTX3, 16 supporting the concept that PTX3 possesses a cardioprotective function.
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We have extended these findings by demonstrating that PTX3 exerts also atheroprotective functions in a mice model. The lack of PTX3 is associated with increased macrophage accumulation in the atherosclerotic lesions and increased bone marrow monocytosis. Of note, the extent of the lesion size correlates with the number of bone marrow monocytes. Furthermore, mice lacking PTX3 show an increased expression of adhesion molecules, cytokines, and chemokines in the vascular wall, thus suggesting that PTX3 may modulate the vascular-associated inflammatory response. Although we cannot exclude that the change in gene expression profiles reflects the differences in lesion size, because increased bone marrow monocytosis and macrophage plaque accumulation were observed, it is reasonable to propose that the increased inflammatory response in the vascular wall may reflect the presence and activation of these cells in PTX3-deficient animals.
Despite initial findings suggesting a potential pathogenic role for PTX3 in cardiovascular disease, recent observations, including our findings, support the possibility that PTX3 may act as a molecule at the crossway between proinflammatory and antiinflammatory stimuli, perhaps balancing the overactivation of a proinflammatory, proatherogenic cascade. Therefore, the increased levels of PTX3 in cardiovascular disease could reflect a protective physiological response, thus correlating with the severity of the disease.
Indeed, vascular wall cells integrate signals generated by multiple factors to regulate the immunoinflammatory response, which is achieved by finely tuning vascular inflammation by antiinflammatory counterregulatory mechanisms that maintain the integrity and homeostasis of the vascular wall. 42 Interestingly, PTX3 is modulated both by proinflammatory proatherogenic molecules 24 and antiinflammatory atheroprotective molecules. 17, 20 Furthermore, although our results point to an atheroprotective function of PTX3, this molecule also possesses proinflammatory and prothrombotic potential; indeed, PTX3 has been reported to induce tissue factor in monocytes and endothelial cells. 36, 43 Therefore, the molecule may have different functions in different settings or temporal windows of vascular pathology. Similar to adaptive immunity in which different players such as Th2 and T-regulatory cells could limit atherosclerosis progression, 44 it is possible that effectors of the humoral arm of the innate immunity such as PTX3 might finely tune the immunoinflammatory response during atherosclerosis. Whether this effect is the result of the interaction of PTX3 with molecules involved in leukocyte recruitment within the lesion and/or in monocyte generation in the bone marrow has to be addressed.
Our study has some limitations. First, we focused our analysis on a selective inflammatory gene expression profile, which implies that we could have missed the modulation of genes involved in different pathogenetic responses. Second, we used a mice model in which PTX3-deficient mice were crossed with ApoE-deficient mice, one of the most widely used models of atherosclerosis, which per se shows a lower basal inflammatory activation in the vascular wall. We cannot exclude that PTX3 deficiency in other atherosclerosisprone models such as low-density lipoprotein receptor-knockout mice might lead to different results.
Conclusions
We have shown that deficiency of the long pentraxin PTX3 in mice is associated with an increased burden of vascular lesions and inflammation in a mouse model of atherosclerosis. This suggests that PTX3 could play an atheroprotective role in addition to its recently reported cardioprotective functions, 16 suggesting that components of the humoral arm of innate immunity such as PTX3 may exert beneficial effects on cardiovascular disease under conditions promoting atherosclerosis. 
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